Table 2.
Incidence Rates and ORs for CHD According to BMI by History of HP in Patients with Type 2 Diabetes
| Low Weight (<18.5 kg/m2) | Normal Weight (18.5–24.9 kg/m2) | Overweight (25.0–29.9 kg/m2) | Mild Obesity (30.0–34.9 kg/m2) | Severe Obesity (≥35.0 kg/m2) | |
|---|---|---|---|---|---|
| Prevalence, n (%) | |||||
| HP | 216(42.7) | 2550(29.0) | 2382(27.8) | 685(31.6) | 83(33.7) |
| No-HP | 52(11.3) | 685(12.1) | 470(13.0) | 73(12.2) | 6(9.4) |
| OR (95% CI) | |||||
| Basic regression modela | |||||
| HP | 1.67(1.37–2.03) | 1.00 (Ref) | 1.02(0.95–1.09) | 1.28(1.14–1.42) | 1.68(1.26–2.25) |
| No-HP | 0.74(0.54–1.01) | 1.00 (Ref)* | 1.25(1.1–1.43) | 1.54(1.17–2.03) | 1.84(0.74–4.55) |
| Main regression modelb | |||||
| HP | 1.78(1.43–2.23) | 1.00 (Ref) | 1.05(0.96–1.13) | 1.27(1.12–1.44) | 1.72(1.24–2.39) |
| No-HP | 0.62(0.44–0.88) | 1.00 (Ref)* | 1.30(1.12–1.51) | 1.69(1.23–2.31) | 2.51(0.85–7.42) |
Notes: aBasic models include adjustment for sex, age, and diabetes duration. bMain models additionally include smoking, drinking, use of antiplatelet, statin, insulin, and metformin, FBG, HbA1c, hypoglycemia, total cholesterol, LDL-C, triglyceride, lipoprotein-a, SCr, and SUA; *The same model as for HP group except patients without hypertension and BMI 18.5–24.9 kg/m2 constitute the reference group.
Abbreviations: CHD, coronary heart disease; BMI, body mass index; HP, hypertension; Ref, reference group; FBG, fasting blood-glucose; HbA1c, glycosylated hemoglobin; LDL-C, low-density lipoprotein cholesterol; SCr, serum creatinine; SUA, serum uric acid.